Journal of Allergy and Clinical Immunology-In Practice

Article	Citations
Telemedicine in the Era of COVID-19	423
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach	320
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic	226
A Consensus Approach to the Primary Prevention of Food Allergy Through Nutrition: Guidance from the American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immuno	170
US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema	159
Chronic Rhinosinusitis with Nasal Polyps and Asthma	156
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach	149
Polyethylene Glycol–Induced Systemic Allergic Reactions (Anaphylaxis)	147
Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic	140
Exercise and Fitness in the Age of Social Distancing During the COVID-19 Pandemic	130
Risk Communication During COVID-19	127
Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist	126
Initial effects of the COVID-19 pandemic on pediatric asthma emergency department utilization	123
Prevalence of Food Sensitization and Food Allergy in Children Across Europe	111
Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden	109
Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness	109
First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing	102
Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients	102
Long-Term Therapy Response to Anti–IL-5 Biologics in Severe Asthma—A Real-Life Evaluation	101
Prevalence of Comorbid Asthma and Related Outcomes in COVID-19: A Systematic Review and Meta-Analysis	101
Pediatric Asthma Health Care Utilization, Viral Testing, and Air Pollution Changes During the COVID-19 Pandemic	101
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs	100
Asthma prolongs intubation in COVID-19	96
Food Allergy from Infancy Through Adulthood	95
Anti-PEG IgE in anaphylaxis associated with polyethylene glycol	85

The Impact of Social Determinants of Health on Children with Asthma	84
Artificial Intelligence/Machine Learning in Respiratory Medicine and Potential Role in Asthma and COPD Diagnosis	80
Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis	79
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis	78
The Challenges and Opportunities for Shared Decision Making Highlighted by COVID-19	77
SARS-CoV-2 Pneumonia in Hospitalized Asthmatic Patients Did Not Induce Severe Exacerbation	72
Clinical Relevance of Cross-Reactivity in Food Allergy	72
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process	71
Endophenotypic Variations of Atopic Dermatitis by Age, Race, and Ethnicity	71
Improving Diagnostic Accuracy in Food Allergy	71
Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect	70
Hereditary Alpha-Tryptasemia: UK Prevalence and Variability in Disease Expression	70
Phenotypes of Chronic Rhinosinusitis	70
Real-World Effectiveness of Omalizumab in Severe Allergic Asthma: A Meta-Analysis of Observational Studies	68
Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma	67
Rapid recovery of a SARS-CoV-2–infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma	66
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes	65
Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City	65
Biologics for the Use in Chronic Spontaneous Urticaria: When and Which	65
The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells	64
Endotypes of Chronic Rhinosinusitis with Nasal Polyps: Pathology and Possible Therapeutic Implications	63
Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS)	62
Health-Related Quality of Life in Common Variable Immunodeficiency Italian Patients Switched to Remote Assistance During the COVID-19 Pandemic	61
Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis	60
COVID-19 Susceptibility in Bronchial Asthma	59
Trends in hospitalizations for asthma during the COVID-19 outbreak in Japan	59
Work Group Report: COVID-19: Unmasking Telemedicine	58
Reduction of allergic rhinitis symptoms with face mask usage during the COVID-19 pandemic	57
Penicillin Allergy Delabeling: A Multidisciplinary Opportunity	56
Complications of switching from anti–IL-5 or anti–IL-5R to dupilumab in corticosteroid-dependent severe asthma	56
Epidemiology of Chronic Rhinosinusitis: Prevalence and Risk Factors	56
Impact of Allergic Rhinitis and Asthma on COVID-19 Infection, Hospitalization, and Mortality	55
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study	55
Digital Health Technology in Asthma: A Comprehensive Scoping Review	54
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity	54
Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years	53
Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry	53
Different Measures of Diet Diversity During Infancy and the Association with Childhood Food Allergy in a UK Birth Cohort Study	52
The Unexpected Risks of COVID-19 on Asthma Control in Children	52
Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps	51
Prospective Assessment of Pediatrician-Diagnosed Food Protein–Induced Allergic Proctocolitis by Gross or Occult Blood	49
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: General Concepts	49
Immunological Responses and Biomarkers for Allergen-Specific Immunotherapy Against Inhaled Allergens	48
An Approach to the Office-Based Practice of Food Oral Immunotherapy	48
Validation of the Angioedema Control Test (AECT)—A Patient-Reported Outcome Instrument for Assessing Angioedema Control	48
The Prevalence of Subtypes of Type 2 Inflammation in an Unselected Population of Patients with Severe Asthma	48
Novel Approaches to Food Allergy Management During COVID-19 Inspire Long-Term Change	47
Which Are the Optimal Criteria for the Diagnosis of Allergic Bronchopulmonary Aspergillosis? A Latent Class Analysis	47
Rhinovirus Infections and Their Roles in Asthma: Etiology and Exacerbations	47
Clinical, Immunological, and Genetic Features in Patients with Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) and IPEX-like Syndrome	46

Earlier aggressive treatment to shorten the duration of eczema in infants resulted in fewer food allergies at 2 years of age	46
Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection	46
Dupilumab Improves Asthma Control and Lung Function in Patients with Insufficient Outcome During Previous Antibody Therapy	45
Use and Interpretation of Acute and Baseline Tryptase in Perioperative Hypersensitivity and Anaphylaxis	45
Prevalence and Burden of Chronic Cough in the United States	45
Geospatial Analysis of Social Determinants of Health Identifies Neighborhood Hot Spots Associated With Pediatric Intensive Care Use for Life-Threatening Asthma	45
Effectiveness of myAirCoach: A mHealth Self-Management System in Asthma	44
Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps	44
Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak	43
Diagnostic Delay in Patients with Eosinophilic Gastritis and/or Duodenitis: A Population-Based Study	43
Potential Severe Asthma Hidden in UK Primary Care	43
Urticaria and Angioedema Across the Ages	43
Acute At Home Management of Anaphylaxis During the Covid-19 Pandemic	42
First Real-World Effectiveness Analysis of Preschool Peanut Oral Immunotherapy	42
2020 NAEPP Guidelines Update and GINA 2021—Asthma Care Differences, Overlap, and Challenges	42
Epidemiology of Nonesophageal Eosinophilic Gastrointestinal Diseases in Symptomatic Patients: A Systematic Review and Meta-Analysis	42
Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions	41
Small Airway Dysfunction Links Asthma Severity with Physical Activity and Symptom Control	41
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study	41
Current and Future Treatments of Rhinitis and Sinusitis	41
Autoimmune Chronic Spontaneous Urticaria Detection with IgG Anti-TPO and Total IgE	41
Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19	40
The Impact of Patient Self-Monitoring Via Electronic Medication Monitor and Mobile App Plus Remote Clinician Feedback on Adherence to Inhaled Corticosteroids: A Randomized Controlled Trial	40
Penicillin Allergy Assessment in Pregnancy: Safety and Impact on Antibiotic Use	39
The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia	39
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study	39
Impact of the COVID-19 pandemic in children with allergic asthma	38
Community Use of Epinephrine for the Treatment of Anaphylaxis: A Review and Meta-Analysis	38
A Slice of Food Protein–Induced Enterocolitis Syndrome (FPIES): Insights from 441 Children with FPIES as Provided by Caregivers in the International FPIES Association	38
Sleep Disturbances and Atopic Dermatitis: Relationships, Methods for Assessment, and Therapies	37
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma	37
Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series	37
Age-Related Differences in Immunological Responses to SARS-CoV-2	37
Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era	37
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice	36
COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach	36
Asthma and Three Colinear Comorbidities: Obesity, OSA, and GERD	36
Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop	36
Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection	36
Basophil Activation Test Reduces Oral Food Challenges to Nuts and Sesame	36
The Expanding Spectrum of Mutations in Hereditary Angioedema	36
SARS-CoV-2 Vaccines: Where Are We Now?	36
A Practical Guide to Implementing SMART in Asthma Management	36
Burden of Specialist-Diagnosed Chronic Cough in Adults	35
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab	35
Endophenotyping Oxaliplatin Hypersensitivity: Personalizing Desensitization to the Atypical Platin	34
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America	34
Treatable Traits That Predict Health Status and Treatment Response in Airway Disease	34
Innate and Adaptive Immunity: ILC2 and Th2 Cells in Upper and Lower Airway Allergic Diseases	34
Risk Factors and Characteristics of Biphasic Anaphylaxis	34
Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies	33
FEF25-75% Is a More Sensitive Measure Reflecting Airway Dysfunction in Patients with Asthma: A Comparison Study Using FEF25-75% and FEV1%	33
The Relationship of Asthma Biologics to Remission for Asthma	33
Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease	32
Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis	32
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results	32
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium	32
Direct Challenges to Penicillin-Based Antibiotics in the Inpatient Setting	32
Lower Use of Biologics for the Treatment of Asthma in Publicly Insured Individuals	32
Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19	32
Pragmatic Clinical Perspective on Biologics for Severe Refractory Type 2 Asthma	32
Trajectory Analyses of Adherence Patterns in a Real-Life Moderate to Severe Asthma Population	32
Risk of Psychiatric Adverse Events Among Montelukast Users	31
Asthma Disease Status, COPD, and COVID-19 Severity in a Large Multiethnic Population	31
A Randomized, Open-Label Trial of Hen's Egg Oral Immunotherapy: Efficacy and Humoral Immune Responses in 50 Children	31
Efficacy and Safety of Ragweed SLIT-Tablet in Children with Allergic Rhinoconjunctivitis in a Randomized, Placebo-Controlled Trial	31
Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion	31
Serum Eosinophil-Derived Neurotoxin Better Reflect Asthma Control Status Than Blood Eosinophil Counts	31
Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis	31
Effect of COVID-19 on asthma exacerbation	31
Bringing the Next Generation of Food Allergy Diagnostics Into the Clinic	31
Targeting Downstream Type 2 Cytokines or Upstream Epithelial Alarmins for Severe Asthma	31
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review	31
Appraisal of the Real-World Effectiveness of Biologic Therapies in Aspirin-Exacerbated Respiratory Disease	31
Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience	31
Clinical and Serological Characterization of the α-Gal Syndrome—Importance of Atopy for Symptom Severity in a European Cohort	30
Comparison of Nonesophageal Eosinophilic Gastrointestinal Disorders with Eosinophilic Esophagitis: A Nationwide Survey	30
Systematic Assessment of Difficult-to-Treat Asthma: Principles and Perspectives	30
COVID-19 infection in 10 common variable immunodeficiency patients in New York City	30
Managing Food Allergy When the Patient Is Not Highly Allergic	30

Estimating COVID-19 Infection and Severity Risks in Patients with Chronic Rhinosinusitis: A Korean Nationwide Cohort Study	30
Advancing Food Allergy Through Epidemiology: Understanding and Addressing Disparities in Food Allergy Management and Outcomes	30
Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate to Severe Atopic Dermatitis	30
Translating Evidence to Optimize Patient Care Using GRADE	30
Advances in IgE Testing for Diagnosis of Allergic Disease	30
Pediatric asthma exacerbations during the COVID-19 pandemic: Absence of the typical fall seasonal spike in Washington, DC	30
COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency	29
REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma	29
Telemedical Asthma Education and Health Care Outcomes for School-Age Children: A Systematic Review	29
Add-On Omalizumab for Inadequately Controlled Severe Pollinosis Despite Standard-of-Care: A Randomized Study	29
The Allergen: Sources, Extracts, and Molecules for Diagnosis of Allergic Disease	29
A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services	29
Diagnosis of Sesame Allergy: Analysis of Current Practice and Exploration of Sesame Component Ses i 1	28
Egg Allergy in US Children	28
Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure	28
Delabeling Delayed Drug Hypersensitivity: How Far Can You Safely Go?	28
Establishing Amoxicillin Allergy in Children Through Direct Graded Oral Challenge (GOC): Evaluating Risk Factors for Positive Challenges, Safety, and Risk of Cross-Reactivity to Cephalosporines	28
Disease-Modifying Effect of Japanese Cedar Pollen Sublingual Immunotherapy Tablets	28
Recent dramatic increase in patients with food protein–induced enterocolitis syndrome (FPIES) provoked by hen’s egg in Japan	28
Patient Satisfaction with In-Person, Video, and Telephone Allergy/Immunology Evaluations During the COVID-19 Pandemic	28
Chronic Respiratory Diseases and the Outcomes of COVID-19: A Nationwide Retrospective Cohort Study of 39,420 Cases	28
Personalized Treatment of Asthma: The Importance of Sex and Gender Differences	28
How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit	28
Wheat Anaphylaxis in Adults Differs from Reactions to Other Types of Food	28
New Perspectives on Difficult Asthma; Sex and Age of Asthma-Onset Based Phenotypes	28
Low Frequency of IgE-Mediated Food Hypersensitivity in Mastocytosis	28
Longitudinal Impact of Sputum Inflammatory Phenotypes on Small Airway Dysfunction and Disease Outcomes in Asthma	27
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)	27
Community Private Practice Clinical Experience with Peanut Oral Immunotherapy	27
The Role of In Vivo and Ex Vivo Diagnostic Tools in Severe Delayed Immune-Mediated Adverse Antibiotic Drug Reactions	27
Hypogammaglobulinemia After Chimeric Antigen Receptor (CAR) T-Cell Therapy: Characteristics, Management, and Future Directions	27
Oral Corticosteroids and Risk of Preterm Birth in the California Medicaid Program	27
A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies	27
The Accuracy of Diagnostic Testing in Determining Tree Nut Allergy: A Systematic Review	27
Usage Patterns of Short-Acting β2-Agonists and Inhaled Corticosteroids in Asthma: A Targeted Literature Review	27
Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic Mastocytosis	27
Ascertainment Bias in Anaphylaxis Safety Data of COVID-19 Vaccines	27
The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World	27
Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)	27
AAAAI Work Group Report: Trends in Oral Food Challenge Practices Among Allergists in the United States	27
Research Priorities in Pediatric Asthma: Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank	27
Peanut-induced food protein–induced enterocolitis syndrome (FPIES) in infants with early peanut introduction	27
Disconnect between effects of mepolizumab on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps	27
Patient Characteristics and Risk Factors for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy	27
Preventive Effect of Allergen Immunotherapy on Asthma and New Sensitizations	26
Collagen—An Important Fish Allergen for Improved Diagnosis	26
Ten Rules for Implementation of a Telemedicine Program to Care for Patients with Asthma	26
Rhinitis Phenotypes	26
A Cost-Effectiveness Analysis of Epinephrine Autoinjector Risk Stratification for Patients with Food Allergy—One Epinephrine Autoinjector or Two?	26
Disparities in Asthma and Allergy Care: What Can We Do?	26
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma and Perennial Allergy	26
Personalized Medication Adherence Management in Asthma and Chronic Obstructive Pulmonary Disease: A Review of Effective Interventions and Development of a Practical Adherence Toolkit	26
A Systematic Review of the Effect of Physical Activity on Asthma Outcomes	26
Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score	26
The Adoption and Implementation of Digital Health Care in the Post–COVID-19 Era	26
Systematic Assessment for Difficult and Severe Asthma Improves Outcomes and Halves Oral Corticosteroid Burden Independent of Monoclonal Biologic Use	26
Omalizumab in IgE-Mediated Food Allergy: A Systematic Review and Meta-Analysis	26
The Psychosocial Burden of Food Allergy Among Adults: A US Population-Based Study	25
Effect of Inhaled Corticosteroids on Exacerbation of Asthma-COPD Overlap According to Different Diagnostic Criteria	25
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma	25
Effects of Aerobic Training Versus Breathing Exercises on Asthma Control: A Randomized Trial	25
Benralizumab for severe DRESS in two COVID-19 patients	25
Quantification of Glucocorticoid-Associated Morbidity in Severe Asthma Using the Glucocorticoid Toxicity Index	25
Sleep Disturbance in School-Aged Children with Atopic Dermatitis: Prevalence and Severity in a Cross-Sectional Sample	25
Food Proteins in Human Breast Milk and Probability of IgE-Mediated Allergic Reaction in Children During Breastfeeding: A Systematic Review	25
Controversies in Allergy: Chemotherapy Reactions, Desensitize, or Delabel?	25
Food-Induced Anaphylaxis in Infants: Can New Evidence Assist with Implementation of Food Allergy Prevention and Treatment?	25
Food Insecure and Allergic in a Pandemic: A Vulnerable Population	25
Clinical Profile and Treatment in Hypereosinophilic Syndrome Variants: A Pragmatic Review	25
Cigarette Smoking and Asthma	25
Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination	25
African American Children Are More Likely to Be Allergic to Shellfish and Finfish: Findings from FORWARD, a Multisite Cohort Study	24
Glycated Hemoglobin A1c, Lung Function, and Hospitalizations Among Adults with Asthma	24
Balancing Cancer Immunotherapy Efficacy and Toxicity	24
“COVID Arm”: Very delayed large injection site reactions to mRNA COVID-19 vaccines	24
Synchronous Telemedicine in Allergy: Lessons Learned and Transformation of Care During the COVID-19 Pandemic	24
COVID-19 Pandemic–Related Reductions in Pediatric Asthma Exacerbations Corresponded with an Overall Decrease in Respiratory Viral Infections	24
Cost-Effectiveness of Biologics for Allergic Diseases	24
Efficacy of Subcutaneous and Sublingual Immunotherapy for House Dust Mite Allergy: A Network Meta-Analysis–Based Comparison	24
Allergy Evaluation of Hypersensitivity to Platinum Salts and Taxanes: A Six-Year Experience	24
The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome	24
Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial	24
Persistent Asthma from Childhood to Adulthood Presents a Distinct Phenotype of Adult Asthma	24
Vaccine Hesitancy: Drivers and How the Allergy Community Can Help	24
Food Insecurity in the Food Allergic Population: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee	24
Direct Challenges for the Evaluation of Beta-Lactam Allergy: Evidence and Conditions for Not Performing Skin Testing	24
Preserved Cellular Immunity Upon Influenza Vaccination in Most Patients with Common Variable Immunodeficiency	23
Peanut Can Be Used as a Reference Allergen for Hazard Characterization in Food Allergen Risk Management: A Rapid Evidence Assessment and Meta-Analysis	23
A Gap Between Asthma Guidelines and Management for Adolescents and Young Adults	23
Peanut oral immunotherapy protects patients from accidental allergic reactions to peanut	23
Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Rα in a real-world setting	23
Dietary Elimination for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis	23
Early Discontinuation of Cow's Milk Protein Ingestion Is Associated with the Development of Cow's Milk Allergy	23
Cell-Based Functional IgE Assays Are Superior to Conventional Allergy Tests for Shrimp Allergy Diagnosis	23
Oral Corticosteroid Treatment Patterns of Patients in the United States with Persistent Asthma	23